Monday, 25 August 2014
INDIAN BENCHMARK opened lower following consistent nervousness due to Supreme Court order on coal block allocation case.
FURTHER, Auro Life Pharma LLC, subsidiary of Aurobindo Pharma has got tentative approval from USFDA for anti-allergy drug fexofenadine hydrochloride 30 mg. Torrent Pharma has secured an exemption from price control for one of its newly developed fixed dose combination products.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Monday while the DIIs were net sellers of Rs. 45cr, as per the provisional figures released by the NSE.
